Key Takeaways
- UBS shifted its rating on Tesla ($TSLA) from Sell to Neutral, maintaining a $352 price target
- The stock has declined over 21% in 2026, trailing the performance of the wider market
- UBS projects just 1.6 million vehicle deliveries for 2026 with modest growth expectations into 2030
- Robotaxi deployment is progressing slower than anticipated; Optimus humanoid robot timeline likely to miss CEO projections
- Analyst notes Tesla’s valuation is driven more by market sentiment than fundamental metrics
UBS has shifted its position on Tesla (TSLA) stock, moving from Sell to Neutral after the electric vehicle maker experienced a significant pullback in 2026.
Joseph Spak, the UBS analyst covering the company, maintained his $352 price objective. The rating change follows a more than 21% year-to-date decline in Tesla shares, significantly underperforming broader equity indexes.
According to Spak, Tesla’s current valuation now presents a more balanced assessment between immediate challenges and its long-term prospects in physical artificial intelligence applications.
Multiple pressures have mounted on the stock. Cooling electric vehicle demand, disappointing first-quarter energy segment results, expanding cost structures, and elevated capital expenditure requirements have all contributed to the decline.
Movement on Tesla’s two highest-profile initiatives — the autonomous robotaxi platform and the Optimus humanoid robot — has lagged behind initial projections.
While upgrading the rating, Spak maintained a cautious tone regarding near-term prospects. He cautioned that shares “may continue to exhibit high volatility” and emphasized that trading activity is influenced more by investor sentiment and future narratives than current financial performance.
From a delivery perspective, UBS is projecting 1.6 million vehicle deliveries in 2026 — essentially unchanged from the prior year. The firm anticipates a compound annual growth rate of approximately 7%, reaching roughly 2 million units by 2030. This forecast falls considerably short of Wall Street’s consensus estimate, which hovers around 3 million vehicles.
Spak attributed the conservative delivery projection to intensifying pressure from Chinese competitors, weakening demand for EVs in the United States, and Tesla’s limited vehicle portfolio.
Robotaxi Expansion Slower Than Expected
Tesla previously communicated plans to launch its autonomous taxi service in nine metropolitan areas during the first half of 2026. However, Spak expressed concern regarding the gradual expansion in Austin.
He doesn’t anticipate significant scale in the immediate future. Over the longer horizon, UBS continues to view Tesla as potentially capable of delivering competitive ride pricing and capturing substantial share in the American robotaxi sector.
Optimus Development Timeline Extended
Regarding Optimus, Spak adopted a reserved outlook. He indicated the initiative “will take longer than Musk’s stated targets” and highlighted supply chain vulnerabilities stemming from current dependence on Chinese component manufacturers.
UBS forecasts approximately 5,000 Optimus units for 2027, scaling to 30,000 by the end of the decade. These figures represent a fraction of CEO Elon Musk’s stated ambitions for large-scale manufacturing beginning in the coming year.
From a valuation perspective, applying a 150x price-to-earnings ratio, Tesla’s trading level suggests $2.33 in 2027 earnings per share. UBS projects $2.35, while analyst consensus stands at $2.47.
Tesla’s current P/E multiple of 325 is identified by multiple financial data sources as elevated compared to estimated intrinsic value.
In positive regulatory developments, the Netherlands recently granted approval for Tesla’s Full Self-Driving system on both highways and urban roads — marking the first such authorization in Europe. This milestone prompted Cantor Fitzgerald to confirm its Overweight rating with a $510 price target.





